In 2017, Roy et al. (2017) were the first to suggest that RARRES1 plays a role in regulating angiogenesis by demonstrating its inhibitory effect on tube formation in HUVECs in the context of prostate cancer. The gene discussed is RARRES1; the disease is prostate carcinoma.